SCHEMBL21035368

SCHEMBL21035368

CC(C)(C)OC(=O)NC1CCN(C(=O)C2CN(C(c3ccc(C(F)(F)F)cc3)C3CCCC3)CCN2S(=O)(=O)c2ccc(OCC3CCCCC3)cc2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 2/20 0.38
MMP1 P03956 7/20 0.37
MMP13 P45452 6/20 0.37
ADAM17 P78536 4/20 0.37
GAA P10253 1/20 0.37
MMP9 P14780 4/20 0.36
RORC P51449 2/20 0.36
EPHX1 P07099 1/20 0.36
EPHX2 P34913 1/20 0.36
MMP3 P08254 2/20 0.35
MMP7 P09237 2/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
KCNQ1 P51787 1/20 0.35
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21036251 1.00 ACACB (0.38) ACACBMMP1MMP13ADAM17GAA
SCHEMBL21035446 0.99 ACACB (0.38) ACACBMMP1MMP13ADAM17GAA
SCHEMBL21035321 0.94 ACACB (0.39) ACACBMMP1MMP13ADAM17GAA
SCHEMBL21002021 0.88 PSEN1 (0.40) MMP1MMP13ADAM17MMP9MMP3
SCHEMBL21035365 0.88 PSEN1 (0.40) MMP1MMP13ADAM17MMP9MMP3
SCHEMBL21002019 0.88 PSEN1 (0.40) MMP1MMP13ADAM17MMP9MMP3
SCHEMBL21002020 0.88 PSEN1 (0.40) MMP1MMP13ADAM17MMP9MMP3
SCHEMBL21002064 0.88 PSEN1 (0.40) MMP1MMP13ADAM17MMP9MMP3
SCHEMBL21035362 0.88 PSEN1 (0.40) MMP1MMP13ADAM17MMP9MMP3
SCHEMBL21035364 0.88 PSEN1 (0.40) MMP1MMP13ADAM17MMP9MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed